Compare Allegion PLC (ALLE) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allegion PLC vs Zoetis Inc — how do they compare? Allegion PLC trades at $136.06 (market cap $11.74B), while Zoetis Inc trades at $75.24 (market cap $31.68B). The key difference: Zoetis Inc is far larger — about 2.7× Allegion PLC's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| ALLE | ZTS | |
|---|---|---|
Market Cap | $11.74B | $31.68B |
Sector | Industrials | Health |
52-Week High | $179.77 | $156.76 |
52-Week Low | $125.65 | $71.91 |
Enterprise Value | $13.46B | $38.97B |
Dividend Yield | 1.55% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALLE trades at $136.36, down 0.2% on the day, with a bearish technical signal. The company reported Q1 2026 earnings of $1.80 per share, missing estimates, but maintains strong profitability with a net margin of 15.24% and ROE of 34.18%. Revenue growth has been consistent, reaching $4.07B in 2025. Analysts maintain a consensus price target of $152.50, with 30.43% recommending Buy and 69.57% Hold.
The outlook for ALLE is cautiously optimistic, supported by solid fundamentals and innovation in security products, but near-term headwinds include recent earnings misses and rising costs. The stock offers potential upside to the consensus target, though investors should monitor execution on guidance and margin pressures.
Zoetis (ZTS) trades at $75.39, down 0.22% on the day, with a bearish technical signal from moving averages. The company shows strong profitability with a 28.03% net income margin and consistent revenue growth, though Q1 2026 EPS missed expectations. Recent news highlights a class action lawsuit filed against the company, potentially impacting investor sentiment.
The stock presents a mixed outlook: robust fundamentals and a consensus price target of $101.43 suggest upside, but legal risks and technical bearishness warrant caution. Investment opportunity hinges on legal resolution and earnings recovery, with risks including litigation outcomes and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allegion PLC
Allegion is a global security products company with a portfolio of leading brands, such as Schlage, von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2021, Allegion generated 68% of sales in the United States. The company mainly competes with Swedish-based Assa Abloy AB and Switzerland-based Dormakaba.
Read more on ALLE →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
